GlassScriptPhysician profile
Lillian D Moore
NPI 1447663398
$3,114.42
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $740 · 2022: $825 · 2023: $905 · 2024: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $991.76 | 2021-2024 | Freestyle Libre 3 |
| Abbvie INC. | $480.83 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $230.37 | 2021-2024 | Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $186.81 | 2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $180.67 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $176.28 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Janssen Pharmaceuticals, INC | $157.16 | 2021-2022 | |
| Lundbeck LLC | $140.95 | 2023-2024 | Rexulti |
| Mylan Specialty L.P. | $128.32 | 2022-2023 | Yupelri |
| Glaxosmithkline, LLC. | $98.03 | 2021-2023 | Arexvy, Shingrix |
| Dexcom, INC. | $87.39 | 2021-2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.62 | 2021 | |
| Novo Nordisk INC | $37.74 | 2021-2023 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $35.04 | 2022 | |
| Noven Therapeutics, LLC | $27.55 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $23.29 | 2021 | |
| Lilly USA, LLC | $23.21 | 2024 | Zepbound, Mounjaro |
| Vyera Pharmaceuticals, LLC | $18.24 | 2021 | |
| Bausch Health US, LLC | $16.42 | 2021 | |
| Pfizer INC. | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.